Evidence map›Paper›PMID 40211749›Full record

ReviewImmunological reviews2025

Coordinated Regulation of Extrafollicular B Cell Responses by IL-12 and IFNγ.

Rebecca A Elsner, Mark J Shlomchik

Abstract readReview
In one paragraph

Review in Immunological reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Frontiers in pharmacology · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. CD4Vaccines · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Rebecca A ElsnerDepartment of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Mark J ShlomchikDepartment of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.ORCID 0000-0002-2152-0959

Funding

Murine Memory B Cell Development and FunctionR01AI043603 · NIAID · YALE UNIVERSITY · PI MARK J SHLOMCHIK · 1998 to 2026
$9.7M
Autoimmunity and Immunopathology Training ProgramT32AI089443 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SHLOMCHIK, MARK J · 2010 to 2024
$6.6M
Signaling and Selection in Germinal Center B CellsR01AI105018 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MARK J SHLOMCHIK · 2014 to 2026
$4.8M
National Institute of Allergy and Infectious Diseases R01-AI043603National Institute of Allergy and Infectious Diseases R01-AI105018National Institute of Allergy and Infectious Diseases R37-AI118841National Institute of Allergy and Infectious Diseases T32-AI060525National Institute of Allergy and Infectious Diseases T32-AI089443NIAID NIH HHS R01 AI043603NIAID NIH HHS R01 AI105018NIAID NIH HHS T32 AI089443
6 · The paper itself

Abstract

Upon activation, B cells undergo either the germinal center (GC) or extrafollicular (EF) response. While GC are known to generate high-affinity memory B cells and long-lived plasma cells, the role of the EF response is less well understood. Initially, it was thought to be limited to that of a source of fast but lower-quality antibodies until the GC can form. However, recent evidence strongly supports the EF response as an important component of the humoral response to infection. EF responses are now also recognized as a source of pathogenic B cells in autoimmune diseases. The EF response itself is dynamic and regulated by pathways that are only recently being uncovered. We have identified that the cytokine IL-12 acts as a molecular switch, enhancing the EF response and suppressing GC through multiple mechanisms. These include direct effects on both B cells themselves and the coordinated differentiation of helper CD4 T cells. Here, we explore this pathway in relation to other recent advancements in our understanding of the EF response's role and highlight areas for future research. A better understanding of how the EF response forms and is regulated is essential for advancing treatments for many disease states.

Indexed as

B-LymphocytesGerminal CenterInterferon-gammaInterleukin-12AnimalsCell DifferentiationHumansImmunity, HumoralLymphocyte ActivationSignal TransductionInterferon-gammaInterleukin-12autoimmunityB cellextrafolliculargerminal centerIL‐12infection

Identifiers

PMID40211749
PMCPMC11986407

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.